SCHEMBL7754898

SCHEMBL7754898

C=CCOc1cc2cc3ccoc3cc2oc1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.53
CYP3A4 P08684 3/20 0.47
HSD17B10 Q99714 2/20 0.47
CYP2A6 P11509 2/20 0.47
KDM4E B2RXH2 2/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
NFKB1 P19838 1/20 0.47
MAOA P21397 1/20 0.47
ACHE P22303 1/20 0.47
CYP2C19 P33261 1/20 0.47
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
CA12 O43570 6/20 0.43
CA1 P00915 6/20 0.43
CA9 Q16790 6/20 0.43
PTGS1 P23219 2/20 0.37
PTGS2 P35354 2/20 0.37
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8897227 0.82 MAOA (0.50) HTTCYP3A4HSD17B10CYP2A6KDM4E
SCHEMBL10336303 0.80 HTT (0.48) HTTCYP3A4HSD17B10CYP2A6KDM4E
SCHEMBL6272780 0.79 CA12 (0.57) CYP3A4CYP2A6KDM4ECA12CA1
SCHEMBL3447032 0.79 MAOA (0.47) HTTCYP3A4HSD17B10CYP2A6KDM4E
SCHEMBL1301705 0.77 CYP3A4 (0.62) HTTCYP3A4HSD17B10CYP2A6KDM4E
SCHEMBL14152660 0.76 KCNA3 (0.51) HTTCYP3A4HSD17B10CYP2A6KDM4E
SCHEMBL8524165 0.76 MAOA (0.38) CYP3A4CYP2A6KDM4ECYP2D6MAOA
SCHEMBL7877813 0.74 SIGMAR1 (0.49) HTTCYP3A4HSD17B10CYP2A6KDM4E
SCHEMBL9222018 0.73 NDUFS8 (0.43) HTTCYP3A4HSD17B10CYP2A6KDM4E
SCHEMBL8524525 0.72 HTT (0.38) HTTCYP3A4HSD17B10CYP2A6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001053301-A1 CHIMERIC MOLECULES CONSISTING OF PSORALEN AND RETINOID, PREPARATION METHOD, USES THEREOF FOR TREATING CELL HYPERPROLIFERATION PATHOLOGIES AND IN PARTICULAR PSORIASIS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2001-07-26 WO disclosed